The opioid crisis is making headlines, but the stimulant category of drugs is emerging as a significant concern. For example, cocaine is flooding Southern states in-line with production increases in South America. Methamphetamine remains an omnipresent scourge, and college students across the country continue to misuse psychostimulants such as Adderall (amphetamine and dextroamphetamine) and Ritalin (methylphenidate) to boost academic performance. The multiple drug epidemics are overwhelming law enforcement and treatment providers.
Against this backdrop, the Institute for the Advancement of Behavioral Healthcare is launching the National Cocaine, Meth & Stimulant Summit to engage stakeholders across the country in discussions about the scope of the issue and best practices in local and national response strategies. The conference will be held November 12-14, 2018, in Fort Lauderdale, Florida.
Clinical professionals, whether part of larger systems or in private practice, are in an ideal position to discuss with their clients why stimulants are no less dangerous than opioids, as well as address the trauma and shame histories that often lead to substance misuse. Law enforcement officials are taking steps to educate their teams and communities about effective strategies for removing these drugs from the streets, and multiple stakeholders are working together to prevent stimulant use, provide access to treatment, and ensure that stimulants are part of larger societal discussions about addressing drug use.
“The National Cocaine, Meth & Stimulant Summit will be the ideal venue to convene stakeholder conversations about addressing stimulant use, particularly during our national opioid crisis,” says Doug Edwards, director of the institute.
More Online: To sign up for updates on the conference and news related to stimulants, visit www.iabhc.com/stimulants.